| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |